Bank of Montreal
ELVN icon

Bank of Montreal’s Enliven Therapeutics ELVN Stock Holding History

Bank of Montreal’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-191,893
Closed -$3.95M – 3913
2023
Q2 		$3.95M Buy
+191,893
New +$3.88M ﹤0.01% 1451
2021
Q2 		– Sell
-59
Closed -$2K – 4028
2021
Q1 		$2K Sell
59
-242
-80% -$12.3K ﹤0.01% 4899
2020
Q4 		$17K Buy
301
+244
+428% +$20.5K ﹤0.01% 4487
2020
Q3 		$4K Sell
57
-42
-42% -$3.79K ﹤0.01% 4496
2020
Q2 		$9K Buy
+99
New +$11.1K ﹤0.01% 4206

Other funds holding ELVN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Bank of Montreal's ELVN Position: Q3 2023 in Review

Bank of Montreal sold out of Enliven Therapeutics (ELVN) in Q3 2023, closing a stake of 191,893 shares — an estimated $3.95M sold.

Bank of Montreal first reported a position in ELVN in Q2 2020 and held it in 5 quarters. The position peaked at $3.95M in Q2 2023. 61 funds tracked by Wall St. Rank hold ELVN as of Q3 2023.

  • Bank of Montreal reported no remaining Enliven Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 191,893 Enliven Therapeutics shares in Q3 2023, an estimated $3.95M.
  • Bank of Montreal first reported a position in Enliven Therapeutics in Q2 2020 and held it in 5 quarters.
  • Bank of Montreal's Enliven Therapeutics position peaked at $3.95M in Q2 2023.
  • 61 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.